Nkarta (NKTX) Assets Average (2020 - 2026)
Nkarta's (NKTX) quarterly Assets Average came in at $388.1 million in Q1 2026, down 20.12% year-on-year from $485.9 million in Q1 2025, and down 6.63% quarter-over-quarter from $415.7 million in Q4 2025.
Nkarta (NKTX) Assets Average (2020 - 2026) Analysis & Trends
Nkarta's Assets Average history runs 7 years deep, the most recent figure standing at $388.1 million for Q1 2026.
- On a quarterly basis, Assets Average fell 20.12% year-over-year to $388.1 million in Q1 2026; TTM through Mar 2026 was $388.1 million, a 20.12% decrease from a year earlier, with the FY2025 full-year figure at $452.7 million, up 2.88% from the prior year.
- Assets Average fell to $388.1 million in Q1 2026 per NKTX's latest filing, from $415.7 million in the prior quarter.
- Across five years, Assets Average topped out at $565.5 million in Q2 2024 and bottomed at $290.1 million in Q1 2022.
- The 5-year median for Assets Average is $459.5 million (2025), against an average of $452.7 million.
- Across the five-year window, Assets Average jumped 72.46% in 2022 and slipped 20.12% in 2026, its largest moves.
- Year by year, Assets Average stood at $488.4 million in 2022, then declined by 19.66% to $392.4 million in 2023, then soared by 31.66% to $516.6 million in 2024, then retreated by 19.53% to $415.7 million in 2025, then slipped by 6.63% to $388.1 million in 2026.
- Per Business Quant, the three latest NKTX Assets Average figures stand at $388.1 million (Q1 2026), $415.7 million (Q4 2025), and $437.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 388.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 388.14 Mn |
| Dec 31, 2025 | 415.72 Mn |
| Sep 30, 2025 | 437.77 Mn |
| Jun 30, 2025 | 459.46 Mn |
| Mar 31, 2025 | 485.91 Mn |
| Dec 31, 2024 | 516.62 Mn |
| Sep 30, 2024 | 543.06 Mn |
| Jun 30, 2024 | 565.51 Mn |
| Mar 31, 2024 | 477.91 Mn |
| Dec 31, 2023 | 392.37 Mn |
| Sep 30, 2023 | 417.45 Mn |
| Jun 30, 2023 | 443.60 Mn |
| Mar 31, 2023 | 465.55 Mn |
| Dec 31, 2022 | 488.37 Mn |
| Sep 30, 2022 | 503.72 Mn |
| Jun 30, 2022 | 404.97 Mn |
| Mar 31, 2022 | 290.10 Mn |
| Dec 31, 2021 | 283.18 Mn |
| Sep 30, 2021 | 300.79 Mn |
| Jun 30, 2021 | 317.40 Mn |